NCT04858958 2025-11-19
FAVOUR
Allist Pharmaceuticals, Inc.
Phase 1 Active not recruiting
Clinical Trials
4 trialsNCT05466149 2025-11-19
Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion
Allist Pharmaceuticals, Inc.
Phase 2 Active not recruiting
NCT06247280 2024-12-06
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
Yuhan Corporation
Active not recruiting
NCT03866499 2024-08-07
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients
Beta Pharma, Inc.
Phase 3 Active not recruiting